Department of Economics, Stockholm School of Economics, Sweden.
Institute of Cancer Policy, King's College London, UK.
Mol Oncol. 2019 Mar;13(3):636-647. doi: 10.1002/1878-0261.12440. Epub 2019 Feb 20.
Health economics is an integrated aspect of all phases of mission-oriented translational cancer research and should be considered an intrinsic component of any study aimed at improving outcomes for patients and intervention costs. Information about value and value for money of new options for prevention and treatment is needed for decisions about their adoption and use by healthcare systems.
健康经济学是面向任务的癌症转化研究所有阶段的综合方面，应被视为旨在改善患者结局和干预成本的任何研究的固有组成部分。需要关于预防和治疗新选择的价值和性价比的信息，以便医疗保健系统做出关于采用和使用这些选择的决策。
